Abstract:
In a first aspect, the present invention relates to an isolated nucleic acid molecule, in particular, an RNA molecule containing particular substitutions. In a further aspect, the present invention relates to a composition comprising the same as well as virus-like particle, viral vector or virus particle containing the nucleic acid molecule according to the present invention. The virus-like particle, the viral vector or the virus particle is suitable for use as a medicament in particular for treating viral infection. Further, a pharmaceutical composition is provided in particular suitable for use as a pharmaceutical prophylactic vaccine containing the virus-like particle, viral vector or the virus particle or the nucleic acid molecule according to the present invention. Finally, a vaccine for vaccination against viral infection, in particular, influenza viral infection is provided as well as a composition or kit comprising the virus-like particle, viral vector or the virus particle according to the present invention or the nucleic acid molecule according to the present invention in a combination with a wild type viral vector or wild type virus particle said composition or kit is suitable for use in treating or protecting against viral infection.
Abstract:
In a first aspect, the present invention relates to a process for the preparation of magnetic sulfated cellulose particles. In particular, the present invention relates to the preparation of magnetic sulfated cellulose particles under specific reaction conditions allowing providing said magnetic sulfated cellulose particles being particularly useful in further process steps including enrichment of proteinaceous compositions. In another aspect, the present invention relates to the magnetic sulfated cellulose particles itself as well as its use for isolation of proteinaceous compositions including composition of virus proteins and/or non-virus proteins as well as whole virus and for enrichment steps in analytical methods. Finally, the present invention provides a method for isolating whole virus or virus proteins as well as isolating heparin binding molecules comprising the step of pseudo-affinity purification using the magnetic sulfated cellulose particles according to the present invention. The present invention relates further to a bioreactor system comprising a bioreactor and a magnetic separation unit useful for separating magnetic sulfated cellulose particles according to the present invention.